Search all ERS
Interstitial Lung Diseases
Respiratory Critical Care
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
ERJ Open Research
European Lung White Book
All ERS guidelines
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
Can vitamin D
supplementation reduce the time to severe asthma exacerbations in children with asthma?
Idan Bokobza, Nour El Hadi, Andrew Bush, Heidi Makrinioti
Breathe, 17 (3) 210071; 10.1183/20734735.0071-2021
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Idan Bokobza, Nour El Hadi, Andrew Bush, Heidi Makrinioti. Can vitamin D
supplementation reduce the time to severe asthma exacerbations in children with asthma?. Breathe, 17 (3) 210071; 10.1183/20734735.0071-2021
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
No comment yet.
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Respiratory sequelae of preterm birth across the life span
Time to breathe: Challenges in the successful management of asthma during conception, pregnancy and delivery
Related content which might interest you:
Vitamin D deficiency and COPD exacerbations: Effect of vitamin D supplementation
Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis
Does vitamin D deficiency worsen the hospital outcome in patients with acute exacerbation COPD?
Source: International Congress 2018 – Nutrition and metabolic syndrome in COPD
Role of vitamin D in asthma severity and control in children
Source: Annual Congress 2012 - Clinical and diagnostic markers and management of paediatric allergic diseases
Vitamin D status during pregnancy and wheezing and asthma during childhood
Source: International Congress 2019 – Aetiology and management of childhood respiratory infections, primary ciliary dyskinesia and asthma
Omalizumab treatment reduces asthma exacerbations in children with moderate or severe persistent asthma
Source: International Congress 2017 – Paediatric asthma: treatment modalities and behavioural issues
The role of vitamin D in severe asthma
Source: International Congress 2017 – Novel mechanisms in asthma
Serum vitamin D levels and exercise-induced bronchoconstriction in children with asthma
Source: Eur Respir J 2011; 37: 1366-1370
Vitamin D deficiency and exacerbation frequency in COPD
Source: Annual Congress 2009 - COPD: exacerbation and clinical problems
Is vitamin D deficiency a risk factor for COPD exacerbations?
Source: Annual Congress 2013 –Environment and lifestyle: associations with respiratory disease
Vitamin D insufficiency in adult asthma: Association with asthma severity and control
Source: Annual Congress 2012 - Monitoring of airway diseases: far from the airways
Early life vitamin D levels and childhood respiratory morbidity and allergic sensitization
Source: International Congress 2018 – Recent insights in childhood asthma and wheezing
Vitamin D intake in pregnancy and respiratory and atopic outcomes in childhood
Source: Annual Congress 2008 - Asthma epidemiology
Dietary factors associated with wheezing and allergic rhinitis in children
Source: Eur Respir J 2003; 22: 772-780
Quintupling inhaled glucocorticoids to prevent childhood asthma exacerbations
Source: International Congress 2018 – Preventing asthma and COPD exacerbations by increasing the inhaled glucocorticoid dose
Omalizumab therapy reduces asthma exacerbations in children with severe allergic (IgE-mediated) asthma irrespective of lung function at baseline
Source: Annual Congress 2009 - Difficult asthma in children: diagnostic and therapeutic challenges
Could montelukast reduce asthma exacerbations?
Source: Annual Congress 2008 - Advances in the treatment and pathogenesis of pulmonary diseases
Vitamin D, exacerbations and hospitalizations in COPD patients
Source: Annual Congress 2013 –COPD diagnosis
Add-on omalizumab therapy reduces clinically significant and severe asthma exacerbations, and improves FEV
in patients with severe persistent allergic asthma irrespective of age
Source: Eur Respir J 2005; 26: Suppl. 49, 48s